nodes	percent_of_prediction	percent_of_DWPC	metapath
Phensuximide—Primidone—epilepsy syndrome	0.163	0.481	CrCtD
Phensuximide—CACNA1G—epilepsy syndrome	0.0954	0.47	CbGaD
Phensuximide—Clobazam—epilepsy syndrome	0.091	0.269	CrCtD
Phensuximide—CACNA1H—epilepsy syndrome	0.0859	0.424	CbGaD
Phensuximide—Diazepam—epilepsy syndrome	0.0846	0.25	CrCtD
Phensuximide—CACNA1G—Trimethadione—epilepsy syndrome	0.0586	0.292	CbGbCtD
Phensuximide—CACNA1I—Zonisamide—epilepsy syndrome	0.039	0.194	CbGbCtD
Phensuximide—CACNA1G—Zonisamide—epilepsy syndrome	0.0293	0.146	CbGbCtD
Phensuximide—CACNA1H—Zonisamide—epilepsy syndrome	0.0237	0.118	CbGbCtD
Phensuximide—CYP2C19—epilepsy syndrome	0.0215	0.106	CbGaD
Phensuximide—Glutethimide—Primidone—epilepsy syndrome	0.0155	0.0688	CrCrCtD
Phensuximide—Ethotoin—Primidone—epilepsy syndrome	0.0143	0.0632	CrCrCtD
Phensuximide—Primidone—Phenobarbital—epilepsy syndrome	0.014	0.062	CrCrCtD
Phensuximide—Antipyrine—Clobazam—epilepsy syndrome	0.0139	0.0615	CrCrCtD
Phensuximide—Primidone—Phenytoin—epilepsy syndrome	0.013	0.0576	CrCrCtD
Phensuximide—Methylphenobarbital—Fosphenytoin—epilepsy syndrome	0.0123	0.0546	CrCrCtD
Phensuximide—Methylphenobarbital—Primidone—epilepsy syndrome	0.0123	0.0546	CrCrCtD
Phensuximide—Methsuximide—Primidone—epilepsy syndrome	0.0123	0.0546	CrCrCtD
Phensuximide—Glutethimide—Phenobarbital—epilepsy syndrome	0.0114	0.0507	CrCrCtD
Phensuximide—Glutethimide—Phenytoin—epilepsy syndrome	0.0106	0.0471	CrCrCtD
Phensuximide—Ethotoin—Phenobarbital—epilepsy syndrome	0.0105	0.0466	CrCrCtD
Phensuximide—Methsuximide—Phenobarbital—epilepsy syndrome	0.00909	0.0403	CrCrCtD
Phensuximide—Methylphenobarbital—Phenobarbital—epilepsy syndrome	0.00909	0.0403	CrCrCtD
Phensuximide—Methsuximide—Phenytoin—epilepsy syndrome	0.00845	0.0374	CrCrCtD
Phensuximide—Methylphenobarbital—Phenytoin—epilepsy syndrome	0.00845	0.0374	CrCrCtD
Phensuximide—Methsuximide—Clobazam—epilepsy syndrome	0.00689	0.0305	CrCrCtD
Phensuximide—Phenindione—Fosphenytoin—epilepsy syndrome	0.00626	0.0277	CrCrCtD
Phensuximide—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00556	0.0278	CbGbCtD
Phensuximide—CYP2C19—Trimethadione—epilepsy syndrome	0.00517	0.0258	CbGbCtD
Phensuximide—CYP2C19—Felbamate—epilepsy syndrome	0.00517	0.0258	CbGbCtD
Phensuximide—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00486	0.0243	CbGbCtD
Phensuximide—Phenindione—Phenytoin—epilepsy syndrome	0.00429	0.019	CrCrCtD
Phensuximide—CYP2C19—Clobazam—epilepsy syndrome	0.00422	0.021	CbGbCtD
Phensuximide—Phenindione—Carbamazepine—epilepsy syndrome	0.00396	0.0175	CrCrCtD
Phensuximide—Phenindione—Oxcarbazepine—epilepsy syndrome	0.00365	0.0162	CrCrCtD
Phensuximide—Phenindione—Clobazam—epilepsy syndrome	0.0035	0.0155	CrCrCtD
Phensuximide—CYP2C19—Carbamazepine—epilepsy syndrome	0.00349	0.0174	CbGbCtD
Phensuximide—Clobazam—Midazolam—epilepsy syndrome	0.00345	0.0153	CrCrCtD
Phensuximide—Clobazam—Oxcarbazepine—epilepsy syndrome	0.00345	0.0153	CrCrCtD
Phensuximide—CYP2C19—Primidone—epilepsy syndrome	0.00326	0.0163	CbGbCtD
Phensuximide—CYP2C19—Phenytoin—epilepsy syndrome	0.00313	0.0156	CbGbCtD
Phensuximide—Diazepam—Clonazepam—epilepsy syndrome	0.00313	0.0139	CrCrCtD
Phensuximide—Clobazam—Diazepam—epilepsy syndrome	0.00308	0.0136	CrCrCtD
Phensuximide—Diazepam—Oxcarbazepine—epilepsy syndrome	0.00298	0.0132	CrCrCtD
Phensuximide—Diazepam—Midazolam—epilepsy syndrome	0.00298	0.0132	CrCrCtD
Phensuximide—CYP2C19—Propofol—epilepsy syndrome	0.00292	0.0146	CbGbCtD
Phensuximide—Diazepam—Clobazam—epilepsy syndrome	0.00286	0.0127	CrCrCtD
Phensuximide—CYP2C19—Phenobarbital—epilepsy syndrome	0.00279	0.0139	CbGbCtD
Phensuximide—CYP2C19—Diazepam—epilepsy syndrome	0.00265	0.0132	CbGbCtD
Phensuximide—CYP2C19—Zonisamide—epilepsy syndrome	0.00258	0.0129	CbGbCtD
Phensuximide—CYP2C19—Valproic Acid—epilepsy syndrome	0.00209	0.0104	CbGbCtD
Phensuximide—CYP2C19—Topiramate—epilepsy syndrome	0.00188	0.00939	CbGbCtD
Phensuximide—CACNA1I—telencephalon—epilepsy syndrome	0.000532	0.188	CbGeAlD
Phensuximide—CACNA1G—telencephalon—epilepsy syndrome	0.000365	0.129	CbGeAlD
Phensuximide—CACNA1I—cerebellum—epilepsy syndrome	0.000295	0.104	CbGeAlD
Phensuximide—CACNA1I—brain—epilepsy syndrome	0.00024	0.0848	CbGeAlD
Phensuximide—CACNA1G—head—epilepsy syndrome	0.000227	0.0802	CbGeAlD
Phensuximide—CACNA1G—nervous system—epilepsy syndrome	0.000215	0.0761	CbGeAlD
Phensuximide—CACNA1G—central nervous system—epilepsy syndrome	0.000207	0.0732	CbGeAlD
Phensuximide—CACNA1G—cerebellum—epilepsy syndrome	0.000203	0.0716	CbGeAlD
Phensuximide—CACNA1G—brain—epilepsy syndrome	0.000164	0.0581	CbGeAlD
Phensuximide—CACNA1H—nervous system—epilepsy syndrome	0.000141	0.0498	CbGeAlD
Phensuximide—CACNA1H—cerebellum—epilepsy syndrome	0.000132	0.0468	CbGeAlD
Phensuximide—Methsuximide—CACNA1G—epilepsy syndrome	0.000109	0.0553	CrCbGaD
Phensuximide—CACNA1H—brain—epilepsy syndrome	0.000108	0.038	CbGeAlD
Phensuximide—Ethotoin—SCN8A—epilepsy syndrome	0.000103	0.0524	CrCbGaD
Phensuximide—Methsuximide—CACNA1H—epilepsy syndrome	9.81e-05	0.0498	CrCbGaD
Phensuximide—Ethotoin—SCN9A—epilepsy syndrome	8.35e-05	0.0424	CrCbGaD
Phensuximide—Ethotoin—SCN3A—epilepsy syndrome	7.98e-05	0.0405	CrCbGaD
Phensuximide—Glutethimide—GABRG2—epilepsy syndrome	7.75e-05	0.0394	CrCbGaD
Phensuximide—Ethotoin—SCN4A—epilepsy syndrome	7.67e-05	0.039	CrCbGaD
Phensuximide—Clobazam—SLC6A1—epilepsy syndrome	7.56e-05	0.0384	CrCbGaD
Phensuximide—Glutethimide—CYP11A1—epilepsy syndrome	6.59e-05	0.0335	CrCbGaD
Phensuximide—Glutethimide—GABRB3—epilepsy syndrome	6.24e-05	0.0317	CrCbGaD
Phensuximide—CACNA1G—Developmental Biology—SCN1A—epilepsy syndrome	6.05e-05	0.00218	CbGpPWpGaD
Phensuximide—Primidone—GRIA2—epilepsy syndrome	6.01e-05	0.0305	CrCbGaD
Phensuximide—CACNA1H—NCAM signaling for neurite out-growth—IL6ST—epilepsy syndrome	5.99e-05	0.00216	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—CNTN2—epilepsy syndrome	5.94e-05	0.00214	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—CNTN2—epilepsy syndrome	5.94e-05	0.00214	CbGpPWpGaD
Phensuximide—CYP2C19—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	5.93e-05	0.00214	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—ANK3—epilepsy syndrome	5.88e-05	0.00212	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—SLIT2—epilepsy syndrome	5.88e-05	0.00212	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—CACNB4—epilepsy syndrome	5.86e-05	0.00212	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—SCN1A—epilepsy syndrome	5.86e-05	0.00212	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—SCN1B—epilepsy syndrome	5.86e-05	0.00212	CbGpPWpGaD
Phensuximide—CYP2C19—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	5.7e-05	0.00206	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—SLIT2—epilepsy syndrome	5.7e-05	0.00205	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—ANK3—epilepsy syndrome	5.7e-05	0.00205	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—SLIT2—epilepsy syndrome	5.69e-05	0.00205	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—ANK3—epilepsy syndrome	5.69e-05	0.00205	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—CACNA1D—epilepsy syndrome	5.66e-05	0.00204	CbGpPWpGaD
Phensuximide—Methylphenobarbital—GRIA2—epilepsy syndrome	5.64e-05	0.0286	CrCbGaD
Phensuximide—CACNA1I—Axon guidance—PRNP—epilepsy syndrome	5.62e-05	0.00203	CbGpPWpGaD
Phensuximide—Ethotoin—SCN1A—epilepsy syndrome	5.61e-05	0.0285	CrCbGaD
Phensuximide—CACNA1G—Developmental Biology—CACNA1H—epilepsy syndrome	5.54e-05	0.002	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—DCX—epilepsy syndrome	5.54e-05	0.002	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—CACNA1D—epilepsy syndrome	5.48e-05	0.00198	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—CACNA1D—epilepsy syndrome	5.48e-05	0.00198	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—GDNF—epilepsy syndrome	5.47e-05	0.00197	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—DCX—epilepsy syndrome	5.36e-05	0.00193	CbGpPWpGaD
Phensuximide—Glutethimide—GABRA1—epilepsy syndrome	5.36e-05	0.0272	CrCbGaD
Phensuximide—CACNA1H—Axon guidance—GDNF—epilepsy syndrome	5.3e-05	0.00191	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—SPTAN1—epilepsy syndrome	5.3e-05	0.00191	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—GDNF—epilepsy syndrome	5.29e-05	0.00191	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—SCN2A—epilepsy syndrome	5.15e-05	0.00186	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—SPTAN1—epilepsy syndrome	5.13e-05	0.00185	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—SPTAN1—epilepsy syndrome	5.13e-05	0.00185	CbGpPWpGaD
Phensuximide—Primidone—GABRG2—epilepsy syndrome	5.03e-05	0.0255	CrCbGaD
Phensuximide—CACNA1H—Developmental Biology—CACNA1G—epilepsy syndrome	4.99e-05	0.0018	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—SCN2A—epilepsy syndrome	4.99e-05	0.0018	CbGpPWpGaD
Phensuximide—CACNA1I—NCAM signaling for neurite out-growth—SRC—epilepsy syndrome	4.95e-05	0.00179	CbGpPWpGaD
Phensuximide—CACNA1I—Axon guidance—ACTB—epilepsy syndrome	4.95e-05	0.00179	CbGpPWpGaD
Phensuximide—Ethotoin—SCN2A—epilepsy syndrome	4.94e-05	0.0251	CrCbGaD
Phensuximide—CACNA1I—Axon guidance—ITGA2—epilepsy syndrome	4.86e-05	0.00175	CbGpPWpGaD
Phensuximide—CACNA1H—Corticotropin-releasing hormone—PRKCB—epilepsy syndrome	4.72e-05	0.0017	CbGpPWpGaD
Phensuximide—CYP2C19—Melatonin metabolism and effects—CYP2D6—epilepsy syndrome	4.58e-05	0.00165	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—CNTN2—epilepsy syndrome	4.38e-05	0.00158	CbGpPWpGaD
Phensuximide—CACNA1H—Corticotropin-releasing hormone—FOS—epilepsy syndrome	4.31e-05	0.00155	CbGpPWpGaD
Phensuximide—CACNA1H—Corticotropin-releasing hormone—POMC—epilepsy syndrome	4.3e-05	0.00155	CbGpPWpGaD
Phensuximide—Primidone—CHRNA7—epilepsy syndrome	4.25e-05	0.0216	CrCbGaD
Phensuximide—CACNA1H—Developmental Biology—CNTN2—epilepsy syndrome	4.24e-05	0.00153	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—TCF4—epilepsy syndrome	4.23e-05	0.00153	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—ANK3—epilepsy syndrome	4.2e-05	0.00151	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—SLIT2—epilepsy syndrome	4.2e-05	0.00151	CbGpPWpGaD
Phensuximide—CACNA1I—Axon guidance—DLG4—epilepsy syndrome	4.16e-05	0.0015	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—PRNP—epilepsy syndrome	4.14e-05	0.00149	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—ANK3—epilepsy syndrome	4.06e-05	0.00147	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—SLIT2—epilepsy syndrome	4.06e-05	0.00147	CbGpPWpGaD
Phensuximide—CACNA1I—Axon guidance—GRIN2B—epilepsy syndrome	4.06e-05	0.00147	CbGpPWpGaD
Phensuximide—Primidone—GABRA5—epilepsy syndrome	4.05e-05	0.0205	CrCbGaD
Phensuximide—CACNA1G—Developmental Biology—CACNA1D—epilepsy syndrome	4.04e-05	0.00146	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—PRNP—epilepsy syndrome	4.01e-05	0.00145	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—PRNP—epilepsy syndrome	4.01e-05	0.00145	CbGpPWpGaD
Phensuximide—Methylphenobarbital—CHRNA7—epilepsy syndrome	3.99e-05	0.0202	CrCbGaD
Phensuximide—Primidone—GRIK2—epilepsy syndrome	3.97e-05	0.0202	CrCbGaD
Phensuximide—CACNA1H—Developmental Biology—CACNA1D—epilepsy syndrome	3.91e-05	0.00141	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—GDNF—epilepsy syndrome	3.9e-05	0.00141	CbGpPWpGaD
Phensuximide—Methylphenobarbital—GABRA5—epilepsy syndrome	3.8e-05	0.0193	CrCbGaD
Phensuximide—CACNA1H—Developmental Biology—GDNF—epilepsy syndrome	3.78e-05	0.00136	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—SPTAN1—epilepsy syndrome	3.78e-05	0.00136	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—CDH2—epilepsy syndrome	3.77e-05	0.00136	CbGpPWpGaD
Phensuximide—Methylphenobarbital—GRIK2—epilepsy syndrome	3.73e-05	0.0189	CrCbGaD
Phensuximide—CYP2C19—Metapathway biotransformation—KCNAB2—epilepsy syndrome	3.68e-05	0.00133	CbGpPWpGaD
Phensuximide—CACNA1I—Axon guidance—ADAM10—epilepsy syndrome	3.66e-05	0.00132	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—SPTAN1—epilepsy syndrome	3.66e-05	0.00132	CbGpPWpGaD
Phensuximide—CACNA1G—NCAM signaling for neurite out-growth—SRC—epilepsy syndrome	3.65e-05	0.00132	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—ACTB—epilepsy syndrome	3.65e-05	0.00132	CbGpPWpGaD
Phensuximide—Clobazam—GABRG2—epilepsy syndrome	3.63e-05	0.0184	CrCbGaD
Phensuximide—CACNA1H—Corticotropin-releasing hormone—BCL2—epilepsy syndrome	3.61e-05	0.0013	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—ITGA2—epilepsy syndrome	3.58e-05	0.00129	CbGpPWpGaD
Phensuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—epilepsy syndrome	3.57e-05	0.00129	CbGpPWpGaD
Phensuximide—Primidone—GABRB2—epilepsy syndrome	3.54e-05	0.018	CrCbGaD
Phensuximide—CACNA1H—NCAM signaling for neurite out-growth—SRC—epilepsy syndrome	3.54e-05	0.00128	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—ACTB—epilepsy syndrome	3.53e-05	0.00127	CbGpPWpGaD
Phensuximide—CACNA1H—Corticotropin-releasing hormone—RELA—epilepsy syndrome	3.53e-05	0.00127	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—ACTB—epilepsy syndrome	3.53e-05	0.00127	CbGpPWpGaD
Phensuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—epilepsy syndrome	3.48e-05	0.00125	CbGpPWpGaD
Phensuximide—Primidone—GABRA1—epilepsy syndrome	3.47e-05	0.0176	CrCbGaD
Phensuximide—CACNA1H—Axon guidance—ITGA2—epilepsy syndrome	3.47e-05	0.00125	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—ITGA2—epilepsy syndrome	3.47e-05	0.00125	CbGpPWpGaD
Phensuximide—CACNA1I—Axon guidance—CDC42—epilepsy syndrome	3.42e-05	0.00123	CbGpPWpGaD
Phensuximide—Primidone—CHRNA4—epilepsy syndrome	3.4e-05	0.0173	CrCbGaD
Phensuximide—Methylphenobarbital—GABRA1—epilepsy syndrome	3.26e-05	0.0165	CrCbGaD
Phensuximide—Methylphenobarbital—CHRNA4—epilepsy syndrome	3.19e-05	0.0162	CrCbGaD
Phensuximide—CACNA1H—Corticotropin-releasing hormone—CASP3—epilepsy syndrome	3.19e-05	0.00115	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—TCF4—epilepsy syndrome	3.12e-05	0.00113	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—DLG4—epilepsy syndrome	3.06e-05	0.00111	CbGpPWpGaD
Phensuximide—CACNA1I—Axon guidance—FYN—epilepsy syndrome	3.05e-05	0.0011	CbGpPWpGaD
Phensuximide—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	3.02e-05	0.00109	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—TCF4—epilepsy syndrome	3.02e-05	0.00109	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—GRIN2B—epilepsy syndrome	3e-05	0.00108	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—DLG4—epilepsy syndrome	2.97e-05	0.00107	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—DLG4—epilepsy syndrome	2.97e-05	0.00107	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—PRNP—epilepsy syndrome	2.96e-05	0.00107	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—GRIN2B—epilepsy syndrome	2.9e-05	0.00105	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—GRIN2B—epilepsy syndrome	2.9e-05	0.00105	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—PRNP—epilepsy syndrome	2.86e-05	0.00103	CbGpPWpGaD
Phensuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	2.84e-05	0.00102	CbGpPWpGaD
Phensuximide—CYP2C19—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	2.8e-05	0.00101	CbGpPWpGaD
Phensuximide—Diazepam—GABRD—epilepsy syndrome	2.8e-05	0.0142	CrCbGaD
Phensuximide—CACNA1G—Developmental Biology—CDH2—epilepsy syndrome	2.78e-05	0.001	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—ADAM10—epilepsy syndrome	2.7e-05	0.000974	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—CDH2—epilepsy syndrome	2.69e-05	0.000971	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—AKT3—epilepsy syndrome	2.68e-05	0.000965	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—ADAM10—epilepsy syndrome	2.62e-05	0.000944	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—ADAM10—epilepsy syndrome	2.61e-05	0.000943	CbGpPWpGaD
Phensuximide—CYP2C19—Melatonin metabolism and effects—APOE—epilepsy syndrome	2.61e-05	0.000943	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—ACTB—epilepsy syndrome	2.6e-05	0.000939	CbGpPWpGaD
Phensuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	2.56e-05	0.000924	CbGpPWpGaD
Phensuximide—Clobazam—GABRB2—epilepsy syndrome	2.56e-05	0.013	CrCbGaD
Phensuximide—CACNA1G—Developmental Biology—ITGA2—epilepsy syndrome	2.56e-05	0.000923	CbGpPWpGaD
Phensuximide—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	2.53e-05	0.000912	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—CDC42—epilepsy syndrome	2.52e-05	0.00091	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—ACTB—epilepsy syndrome	2.52e-05	0.00091	CbGpPWpGaD
Phensuximide—CACNA1I—Axon guidance—KDR—epilepsy syndrome	2.51e-05	0.000906	CbGpPWpGaD
Phensuximide—Clobazam—GABRA1—epilepsy syndrome	2.51e-05	0.0127	CrCbGaD
Phensuximide—CACNA1H—Developmental Biology—ITGA2—epilepsy syndrome	2.48e-05	0.000894	CbGpPWpGaD
Phensuximide—Methsuximide—CYP2C19—epilepsy syndrome	2.45e-05	0.0125	CrCbGaD
Phensuximide—CACNA1H—Axon guidance—CDC42—epilepsy syndrome	2.44e-05	0.000881	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—CDC42—epilepsy syndrome	2.44e-05	0.000881	CbGpPWpGaD
Phensuximide—CACNA1I—Axon guidance—IL6ST—epilepsy syndrome	2.41e-05	0.000868	CbGpPWpGaD
Phensuximide—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	2.3e-05	0.00083	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—FYN—epilepsy syndrome	2.25e-05	0.00081	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—HES1—epilepsy syndrome	2.24e-05	0.000806	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—DLG4—epilepsy syndrome	2.19e-05	0.000789	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—FYN—epilepsy syndrome	2.17e-05	0.000785	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—FYN—epilepsy syndrome	2.17e-05	0.000784	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—MEF2C—epilepsy syndrome	2.16e-05	0.00078	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—GRIN2B—epilepsy syndrome	2.14e-05	0.000771	CbGpPWpGaD
Phensuximide—Diazepam—GABRG2—epilepsy syndrome	2.12e-05	0.0108	CrCbGaD
Phensuximide—CACNA1H—Developmental Biology—DLG4—epilepsy syndrome	2.12e-05	0.000764	CbGpPWpGaD
Phensuximide—Antipyrine—CYP2C19—epilepsy syndrome	2.11e-05	0.0107	CrCbGaD
Phensuximide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	2.08e-05	0.000749	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—GRIN2B—epilepsy syndrome	2.07e-05	0.000747	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—AKT3—epilepsy syndrome	1.97e-05	0.000712	CbGpPWpGaD
Phensuximide—CYP2C19—Arachidonic acid metabolism—GPX1—epilepsy syndrome	1.97e-05	0.00071	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—ADAM10—epilepsy syndrome	1.93e-05	0.000695	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—AKT3—epilepsy syndrome	1.91e-05	0.000689	CbGpPWpGaD
Phensuximide—Glutethimide—CYP2D6—epilepsy syndrome	1.87e-05	0.00948	CrCbGaD
Phensuximide—CACNA1H—Developmental Biology—ADAM10—epilepsy syndrome	1.87e-05	0.000673	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—KDR—epilepsy syndrome	1.85e-05	0.000668	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—CDC42—epilepsy syndrome	1.8e-05	0.000649	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—KDR—epilepsy syndrome	1.79e-05	0.000647	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—KDR—epilepsy syndrome	1.79e-05	0.000646	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—IL6ST—epilepsy syndrome	1.77e-05	0.00064	CbGpPWpGaD
Phensuximide—Tranylcypromine—CYP2C19—epilepsy syndrome	1.77e-05	0.00901	CrCbGaD
Phensuximide—Ethotoin—CYP2C19—epilepsy syndrome	1.76e-05	0.00894	CrCbGaD
Phensuximide—CACNA1H—Developmental Biology—CDC42—epilepsy syndrome	1.74e-05	0.000629	CbGpPWpGaD
Phensuximide—CACNA1H—Corticotropin-releasing hormone—AKT1—epilepsy syndrome	1.72e-05	0.000622	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—IL6ST—epilepsy syndrome	1.72e-05	0.00062	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—IL6ST—epilepsy syndrome	1.72e-05	0.00062	CbGpPWpGaD
Phensuximide—Diazepam—GABRA5—epilepsy syndrome	1.71e-05	0.00866	CrCbGaD
Phensuximide—Diazepam—GABRB3—epilepsy syndrome	1.71e-05	0.00866	CrCbGaD
Phensuximide—CACNA1G—Developmental Biology—HES1—epilepsy syndrome	1.65e-05	0.000595	CbGpPWpGaD
Phensuximide—Primidone—CYP2C19—epilepsy syndrome	1.63e-05	0.00829	CrCbGaD
Phensuximide—CACNA1G—Developmental Biology—FYN—epilepsy syndrome	1.6e-05	0.000578	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—HES1—epilepsy syndrome	1.6e-05	0.000576	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—MEF2C—epilepsy syndrome	1.59e-05	0.000575	CbGpPWpGaD
Phensuximide—Antipyrine—CYP2D6—epilepsy syndrome	1.56e-05	0.00794	CrCbGaD
Phensuximide—CACNA1H—Developmental Biology—FYN—epilepsy syndrome	1.55e-05	0.00056	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—MEF2C—epilepsy syndrome	1.54e-05	0.000557	CbGpPWpGaD
Phensuximide—CACNA1I—Axon guidance—MMP9—epilepsy syndrome	1.54e-05	0.000556	CbGpPWpGaD
Phensuximide—Methylphenobarbital—CYP2C19—epilepsy syndrome	1.53e-05	0.00777	CrCbGaD
Phensuximide—Diazepam—GABRB2—epilepsy syndrome	1.49e-05	0.00758	CrCbGaD
Phensuximide—Diazepam—GABRA1—epilepsy syndrome	1.46e-05	0.00743	CrCbGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	1.43e-05	0.000516	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	1.43e-05	0.000516	CbGpPWpGaD
Phensuximide—CACNA1I—Axon guidance—SRC—epilepsy syndrome	1.42e-05	0.000512	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—FGF2—epilepsy syndrome	1.39e-05	0.000501	CbGpPWpGaD
Phensuximide—CACNA1I—Axon guidance—VEGFA—epilepsy syndrome	1.38e-05	0.000499	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—KDR—epilepsy syndrome	1.32e-05	0.000476	CbGpPWpGaD
Phensuximide—Tranylcypromine—CYP2D6—epilepsy syndrome	1.32e-05	0.00668	CrCbGaD
Phensuximide—Antipyrine—PTGS2—epilepsy syndrome	1.31e-05	0.00667	CrCbGaD
Phensuximide—CACNA1I—Developmental Biology—RELA—epilepsy syndrome	1.29e-05	0.000465	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—KDR—epilepsy syndrome	1.28e-05	0.000461	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—IL6ST—epilepsy syndrome	1.27e-05	0.000457	CbGpPWpGaD
Phensuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.25e-05	0.000453	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—IL6ST—epilepsy syndrome	1.23e-05	0.000442	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—CYP11A1—epilepsy syndrome	1.22e-05	0.000441	CbGpPWpGaD
Phensuximide—CYP2C19—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.21e-05	0.000435	CbGpPWpGaD
Phensuximide—Clobazam—CYP2C19—epilepsy syndrome	1.18e-05	0.00599	CrCbGaD
Phensuximide—CYP2C19—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	1.16e-05	0.000418	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—MMP9—epilepsy syndrome	1.14e-05	0.00041	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—CYP2D6—epilepsy syndrome	1.1e-05	0.000398	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—MMP9—epilepsy syndrome	1.1e-05	0.000397	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—MMP9—epilepsy syndrome	1.1e-05	0.000397	CbGpPWpGaD
Phensuximide—CYP2C19—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.09e-05	0.000392	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	1.08e-05	0.000391	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—SRC—epilepsy syndrome	1.05e-05	0.000378	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—FGF2—epilepsy syndrome	1.02e-05	0.000369	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—VEGFA—epilepsy syndrome	1.02e-05	0.000368	CbGpPWpGaD
Phensuximide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.02e-05	0.000367	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—SRC—epilepsy syndrome	1.01e-05	0.000366	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—SRC—epilepsy syndrome	1.01e-05	0.000366	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	9.92e-06	0.000358	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—FGF2—epilepsy syndrome	9.92e-06	0.000358	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—VEGFA—epilepsy syndrome	9.87e-06	0.000356	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—VEGFA—epilepsy syndrome	9.87e-06	0.000356	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	9.55e-06	0.000345	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—RELA—epilepsy syndrome	9.51e-06	0.000343	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—RELA—epilepsy syndrome	9.21e-06	0.000332	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	8.67e-06	0.000313	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—TNF—epilepsy syndrome	8.46e-06	0.000305	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CA13—epilepsy syndrome	8.41e-06	0.000303	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—MMP9—epilepsy syndrome	8.1e-06	0.000292	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—MMP9—epilepsy syndrome	7.85e-06	0.000283	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—SRC—epilepsy syndrome	7.47e-06	0.00027	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—VEGFA—epilepsy syndrome	7.28e-06	0.000263	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—SRC—epilepsy syndrome	7.24e-06	0.000261	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—VEGFA—epilepsy syndrome	7.05e-06	0.000254	CbGpPWpGaD
Phensuximide—Diazepam—CYP2C19—epilepsy syndrome	6.88e-06	0.00349	CrCbGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	6.77e-06	0.000244	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—L2HGDH—epilepsy syndrome	6.37e-06	0.00023	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CERS1—epilepsy syndrome	6.37e-06	0.00023	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ADK—epilepsy syndrome	6.37e-06	0.00023	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—FAR1—epilepsy syndrome	6.37e-06	0.00023	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PDXK—epilepsy syndrome	6.37e-06	0.00023	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GLUD1—epilepsy syndrome	6.37e-06	0.00023	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—AKT1—epilepsy syndrome	6.3e-06	0.000227	CbGpPWpGaD
Phensuximide—Clobazam—ABCB1—epilepsy syndrome	6.24e-06	0.00317	CrCbGaD
Phensuximide—CACNA1G—Developmental Biology—TNF—epilepsy syndrome	6.24e-06	0.000225	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—TNF—epilepsy syndrome	6.04e-06	0.000218	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—NHLRC1—epilepsy syndrome	5.83e-06	0.00021	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GAMT—epilepsy syndrome	5.83e-06	0.00021	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—EPM2A—epilepsy syndrome	5.83e-06	0.00021	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PNPO—epilepsy syndrome	5.83e-06	0.00021	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CA4—epilepsy syndrome	5.42e-06	0.000196	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—QDPR—epilepsy syndrome	5.42e-06	0.000196	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—POMC—epilepsy syndrome	5.4e-06	0.000195	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—COX3—epilepsy syndrome	5.1e-06	0.000184	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PFKL—epilepsy syndrome	4.83e-06	0.000174	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CACNA2D2—epilepsy syndrome	4.83e-06	0.000174	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—SLCO1A2—epilepsy syndrome	4.83e-06	0.000174	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—KCNB1—epilepsy syndrome	4.83e-06	0.000174	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—SLC6A8—epilepsy syndrome	4.83e-06	0.000174	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	4.69e-06	0.000169	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—AKT1—epilepsy syndrome	4.64e-06	0.000167	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—AKT1—epilepsy syndrome	4.5e-06	0.000162	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—NEU1—epilepsy syndrome	4.42e-06	0.000159	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ATIC—epilepsy syndrome	4.42e-06	0.000159	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—UPB1—epilepsy syndrome	4.42e-06	0.000159	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	4.25e-06	0.000153	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GBE1—epilepsy syndrome	4.11e-06	0.000148	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	4.11e-06	0.000148	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	4.02e-06	0.000145	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	3.86e-06	0.000139	CbGpPWpGaD
Phensuximide—Diazepam—ALB—epilepsy syndrome	3.82e-06	0.00194	CrCbGaD
Phensuximide—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	3.76e-06	0.000136	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—NT5E—epilepsy syndrome	3.66e-06	0.000132	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ALAD—epilepsy syndrome	3.66e-06	0.000132	CbGpPWpGaD
Phensuximide—Diazepam—ABCB1—epilepsy syndrome	3.64e-06	0.00185	CrCbGaD
Phensuximide—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	3.49e-06	0.000126	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	3.49e-06	0.000126	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	3.42e-06	0.000123	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ADSL—epilepsy syndrome	3.35e-06	0.000121	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GLUL—epilepsy syndrome	3.28e-06	0.000118	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	3.22e-06	0.000116	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	3.02e-06	0.000109	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—AQP1—epilepsy syndrome	2.93e-06	0.000106	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.81e-06	0.000101	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	2.65e-06	9.55e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	2.65e-06	9.55e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.47e-06	8.89e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.42e-06	8.71e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	2.16e-06	7.79e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	2.09e-06	7.54e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.07e-06	7.49e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.89e-06	6.83e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.89e-06	6.81e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.8e-06	6.48e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.79e-06	6.45e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.71e-06	6.15e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.69e-06	6.09e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—TH—epilepsy syndrome	1.68e-06	6.07e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.66e-06	5.97e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.4e-06	5.06e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.38e-06	4.99e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.35e-06	4.86e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.25e-06	4.52e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.1e-06	3.96e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.08e-06	3.88e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—POMC—epilepsy syndrome	9.24e-07	3.33e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ALB—epilepsy syndrome	8.42e-07	3.04e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	7.37e-07	2.66e-05	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—AKT1—epilepsy syndrome	3.7e-07	1.34e-05	CbGpPWpGaD
